Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03099863 · ClinicalTrials.gov registry record · Phase 4
Cytoscopic Antibiotic Irrigant to Reduce Postoperative Urinary Tract Infection
A Phase 4 study, sponsored by MetroHealth Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 242
- Enrollment target
NCT03099863: Completed Phase 4 study, sponsored by MetroHealth Medical Center.
NCT03099863 is a Phase 4 study that has completed, run by MetroHealth Medical Center. The registered enrollment target is 242 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (53% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03099863, a Phase 4 study, has completed, sponsored by MetroHealth Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 242 participants
- Enrollment target
Study Summary
Postoperative urinary tract infections (UTIs) affect 20-30% of patients undergoing elective gynecologic surgery and have a significant socioeconomic impact and cost. Preoperative antibiotics, sterile operating techniques, postoperative antibiotic and non-antibiotic medical therapies have been utilized to attempt to decrease this rate with little improvement. Utilization of an intraoperative antibiotic cystoscopic irrigant may decrease postoperative UTIs. The investigators have designed a prospective randomized controlled study to evaluate the effectiveness of an antibiotic cystoscopic fluid in preventing postoperative urinary tract infections in women undergoing elective pelvic floor surgery with cystoscopy.
Primary Outcome
Urinary tract infection defined as positive urinalysis, urine culture, and/or positive lower urinary tract symptoms requiring antibiotic treatment.
Interventions
- PROCEDURE Cystoscopy
- DRUG Cystoscopic Fluid containing Neosporin G. U. Irrigant
- DRUG Cystoscopic Fluid/Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 242 participants |
| Start Date | 2016-04 |
| Est. Completion | 2020-06 |
| Phase | Phase 4 |
What the finished NCT03099863 record still lists
NCT03099863 is an interventional study that assigns participants to a tested intervention. The registered 242 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (53% lower).
The record links to 0 conditions, and to 3 interventions - of which Cystoscopy is the first listed.
NCT03099863 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03099863 about?
NCT03099863 is a clinical study titled "Cytoscopic Antibiotic Irrigant to Reduce Postoperative Urinary Tract Infection". Postoperative urinary tract infections (UTIs) affect 20-30% of patients undergoing elective gynecologic surgery and have a significant socioeconomic impact and cost. Preoperative antibiotics, sterile operating techniques, postoperative antibiotic and non-antibiotic medical therapies have been utiliz...
What is the current status of trial NCT03099863?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 242 participants. The study started on 2016-04. Estimated completion is 2020-06.
What interventions are being tested in trial NCT03099863?
The interventions under investigation include: Cystoscopy (PROCEDURE), Cystoscopic Fluid containing Neosporin G. U. Irrigant (DRUG), Cystoscopic Fluid/Placebo (DRUG).
Who is sponsoring clinical trial NCT03099863?
This trial is sponsored by MetroHealth Medical Center, which has 76 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03099863's enrollment target sits among peer trials
242 358th of 2000 higher than 1,641 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03556228 · 242 participants · Phase 1
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
- NCT04260022 · 242 participants · Phase 1
Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL
- NCT04459000 · 242 participants · NA
Substance Use Treatment and Access to Resources (STARS) Project
- NCT05644496 · 242 participants · Phase 4
ZYNRELEF for Pain Management in Total Knee Arthroplasty
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia